Total Payments
$10,704
2024 Payments
$1,817
Companies
5
Transactions
25
Medicare Patients
1,864
Medicare Billing
$256,120
Payment Breakdown by Category
Other$5,500 (51.4%)
Travel$3,514 (32.8%)
Food & Beverage$1,689 (15.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $5,500 | 2 | 51.4% |
| Travel and Lodging | $3,514 | 7 | 32.8% |
| Food and Beverage | $1,689 | 16 | 15.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Telix Pharmaceuticals | $8,591 | 12 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $1,731 | 10 | $0 (2024) |
| Blue Earth Diagnostics Limited | $254.95 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $92.12 | 1 | $0 (2022) |
| GE HEALTHCARE | $34.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,817 | 9 | Telix Pharmaceuticals ($1,256) |
| 2023 | $4,743 | 13 | Telix Pharmaceuticals ($3,284) |
| 2022 | $4,144 | 3 | Telix Pharmaceuticals ($4,051) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $159.42 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/03/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $34.41 | General |
| 11/13/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $254.95 | General |
| Category: Diagnostic Imaging | ||||||
| 08/27/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $134.81 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/07/2024 | Telix Pharmaceuticals | — | Travel and Lodging | Cash or cash equivalent | $873.13 | General |
| 06/07/2024 | Telix Pharmaceuticals | — | Food and Beverage | In-kind items and services | $47.51 | General |
| 06/07/2024 | Telix Pharmaceuticals | — | Food and Beverage | In-kind items and services | $40.97 | General |
| 06/05/2024 | Siemens Medical Solutions USA, Inc. | Biograph Vision 600 (8 Ring/64 CT) (Device) | Food and Beverage | In-kind items and services | $118.37 | General |
| Category: MI - Nuclear Medicine (incl. PETNET & MIBR) | ||||||
| 05/07/2024 | Siemens Medical Solutions USA, Inc. | Biograph Vision 600 (8 Ring/64 CT) (Device) | Food and Beverage | In-kind items and services | $153.67 | General |
| Category: MI - Nuclear Medicine (incl. PETNET & MIBR) | ||||||
| 11/02/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $206.32 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/09/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $244.01 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/07/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/23/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Travel and Lodging | Cash or cash equivalent | $440.61 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 05/19/2023 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $208.47 | General |
| 05/18/2023 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $28.12 | General |
| 05/18/2023 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $8.33 | General |
| 05/17/2023 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $254.15 | General |
| 05/17/2023 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $92.61 | General |
| 05/15/2023 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $22.28 | General |
| 04/27/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Travel and Lodging | Cash or cash equivalent | $892.65 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 04/19/2023 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $834.39 | General |
| 04/19/2023 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $11.00 | General |
| 11/28/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $92.12 | General |
| 11/08/2022 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Honoraria | Cash or cash equivalent | $4,000.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/11/2022 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $51.42 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 329 | 337 | $188,041 | $34,366 |
| 2022 | 10 | 474 | 492 | $300,201 | $57,135 |
| 2021 | 11 | 487 | 502 | $313,258 | $56,234 |
| 2020 | 10 | 574 | 605 | $443,989 | $108,384 |
Total Patients
1,864
Total Services
1,936
Medicare Billing
$256,120
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 20 | 20 | $71,585 | $14,523 | 20.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 12 | 12 | $8,604 | $4,964 | 57.7% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2023 | 84 | 87 | $14,964 | $2,884 | 19.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 34 | 35 | $11,065 | $2,034 | 18.4% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 16 | 16 | $8,992 | $1,538 | 17.1% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Facility | 2023 | 25 | 25 | $35,428 | $1,458 | 4.1% |
| 78830 | Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | Facility | 2023 | 25 | 25 | $7,033 | $1,427 | 20.3% |
| 79101 | Radioactive drug therapy through a vein | Facility | 2023 | 12 | 16 | $6,239 | $1,279 | 20.5% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Facility | 2023 | 38 | 38 | $5,863 | $1,101 | 18.8% |
| 78812 | Nuclear medicine study from skull base to mid-thigh | Facility | 2023 | 13 | 13 | $7,618 | $991.77 | 13.0% |
| 78582 | Nuclear medicine study of lung ventilation and circulation | Facility | 2023 | 21 | 21 | $4,349 | $884.31 | 20.3% |
| 78708 | Nuclear medicine study of kidney, blood, flow, and function with drug administration | Facility | 2023 | 16 | 16 | $3,728 | $756.32 | 20.3% |
| 78315 | Nuclear medicine study of bone taken at different times | Facility | 2023 | 13 | 13 | $2,573 | $525.20 | 20.4% |
| 78812 | Nuclear medicine study from skull base to mid-thigh | Office | 2022 | 44 | 45 | $115,544 | $25,036 | 21.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 118 | 118 | $36,523 | $7,691 | 21.1% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 18 | 19 | $22,167 | $6,944 | 31.3% |
| 78812 | Nuclear medicine study from skull base to mid-thigh | Facility | 2022 | 92 | 93 | $54,498 | $6,937 | 12.7% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2022 | 80 | 91 | $15,834 | $3,051 | 19.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2022 | 25 | 26 | $14,612 | $2,529 | 17.3% |
| 79101 | Radioactive drug therapy through a vein | Facility | 2022 | 19 | 22 | $8,810 | $1,709 | 19.4% |
| 78830 | Nuclear medicine study, 1 area with spect and concurrent ct scan | Facility | 2022 | 21 | 21 | $6,122 | $1,177 | 19.2% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Facility | 2022 | 14 | 14 | $19,544 | $775.28 | 4.0% |
| 78580 | Nuclear medicine study of lung circulation | Facility | 2022 | 24 | 24 | $3,546 | $728.39 | 20.5% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Facility | 2022 | 19 | 19 | $3,001 | $557.56 | 18.6% |
| 78812 | Nuclear medicine imaging from skull base to mid-thigh | Office | 2021 | 30 | 30 | $106,365 | $23,685 | 22.3% |
About Dr. Pedram Heidari, M.D
Dr. Pedram Heidari, M.D is a Diagnostic Radiology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1396184586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pedram Heidari, M.D has received a total of $10,704 in payments from pharmaceutical and medical device companies, with $1,817 received in 2024. These payments were reported across 25 transactions from 5 companies. The most common payment nature is "Honoraria" ($5,500).
As a Medicare-enrolled provider, Heidari has provided services to 1,864 Medicare beneficiaries, totaling 1,936 services with total Medicare billing of $256,120. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Boston, MA
- Active Since 06/20/2013
- Last Updated 03/17/2018
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1396184586
Products in Payments
- ILLUCCIX (Drug) $7,629
- Biograph Vision 600 (8 Ring/64 CT) (Device) $272.04
- POSLUMA (Drug) $254.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Boston
Andrew Kompel, M.d, M.D
Diagnostic Radiology — Payments: $3.4M
Diagnostic Radiology $3.4M
Gregg Miller, M.d, M.D
Diagnostic Radiology — Payments: $3.0M
Diagnostic Radiology $3.0M
Stephan Anderson, M.d, M.D
Diagnostic Radiology — Payments: $2.4M
Diagnostic Radiology $2.4M
Ashraf Thabet, M.d, M.D
Diagnostic Radiology — Payments: $1.7M
Diagnostic Radiology $1.7M
Dr. Mukesh Harisinghani, Md, MD
Diagnostic Radiology — Payments: $1.4M
Diagnostic Radiology $1.4M
Subba Digumarthy, Md, MD
Diagnostic Radiology — Payments: $1.1M
Diagnostic Radiology $1.1M